Capromab pendetide
Capromab Pendetide
Capromab pendetide (pronunciation: kap-ROE-mab pen-DEE-tide) is a monoclonal antibody used in the detection of prostate cancer. It is also known by its brand name, ProstaScint.
Etymology
The name "capromab pendetide" is derived from the components of the drug itself. "Capro-" refers to the caprylic acid used in the drug's formulation, "-mab" is a suffix used in the naming of monoclonal antibodies, and "pendetide" refers to the pentetic acid used as a chelating agent.
Usage
Capromab pendetide is used in nuclear medicine to detect the spread of prostate cancer to lymph nodes or other parts of the body. It works by binding to a specific antigen found on the surface of prostate cancer cells, allowing them to be detected by a special type of imaging called a SPECT scan.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Prostate cancer: A type of cancer that occurs in the prostate — a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm.
- Nuclear medicine: A medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease.
- SPECT scan: A type of nuclear imaging test that uses a radioactive substance and a special camera to create 3-D pictures.
See Also
External links
- Medical encyclopedia article on Capromab pendetide
- Wikipedia's article - Capromab pendetide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski